The Hon. Nalin Bandara Jayamaha
Hon. Nalin Bandara Jayamaha raised concern over WHO findings of bacterial contamination and saline water in immunoglobulin supplies, noting that the matter is before court and has damaged confidence in Sri Lanka’s healthcare system. He urged the Minister and Government to restore public trust in medicines and act swiftly to address medicine shortages. He also highlighted the Synergy Pharmaceuticals investment at the Bingiriya Export Processing Zone, calling for Treasury facilitation and tax benefits to expedite the USD 100 million project.
Verbatim record (translated)
Machine-translated from Sinhala / Tamil / English¶ 01 We have seen WHO test findings confirming bacterial contamination and saline water in immunoglobulin supplies, which is a grave matter, now before court with action against officials. This is a black mark on a country proud of free, high-quality healthcare. The public’s confidence in medicines must be restored—this is a major responsibility of the Minister, you, and the Government.
¶ 02 I also note Bingiriya Export Processing Zone: in 2019 we commenced the largest pharmaceutical manufacturing plant in South Asia there. The Minister recently visited; I thank Hon. Nalinda Jayatissa as well. Synergy Pharmaceuticals Corporation (Pvt) Ltd is investing about USD 100 million. With Treasury facilitation and tax benefits, this can be expedited, helping solve medicine shortages. Please act swiftly, extend needed facilitation, and restore confidence domestically and internationally.
Provenance
- Source
- Hansard, Friday, 20 June 2025 ·No. 1751600792021434 ·English daily/uncorrected Hansard
- Page · column
- not yet extracted — page/column anchors are not in the current dataset; the source PDF is the citable location.
- Permalink
/lk/speeches/1824
Cite as: The Hon. Nalin Bandara Jayamaha. 10th Parliament, Parliament of Sri Lanka. Hansard, 20 June 2025. No. 1751600792021434. Politick, https://staging.politick.io/lk/speeches/1824